The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q1 2016 call → NOWe need answer only YES or NO. Need analyze transcript. Need determine if management conveys recently finished heavy phase of major undertaking and now collecting phase, with reported results still reflecting paying phase rather than collecting. We need identify major undertaking: likely A350 program ramp-up, or 787? Let's parse. Larry: "Relative to the A350 program, we continued to make progress. We delivered 14 shipsets, with an average deferred inventory, per ship set, of $400,000, as compared to $1.2 million in 4Q 2015 and $3.6 million in the same period last year." Later: "as you're ramping up in rate... this is probably -- there's a number of really challenging periods as you mature your production line. You're getting to your ultimate rate. Maybe the most difficult is the ending of the engineering phase and the beginning of the production phase because there are so many changes that are making their way into your production line. Thank goodness for the most part that's behind us. Change traffic is very small in comparison to what it had been historically. So today as we ramp up in rate, we're just dealing with the machinery..." This suggests heavy phase (engineering changes) behind, now ramp-up. But is collecting phase begun? A350 deferred inventory per shipset down from $3.6M to $400k, but still deferred inventory, not yet profitable? They say "we continue to make progress in reducing our deferred growth per shipset, there is still a lot more work to do." They don't say breakeven. They say "we're feeling really good as you can see but there will be some challenges during the year... transitional years." So heavy phase? The engineering phase behind, but production ramp-up still ongoing, costs still. Is benefit beginning? Deferred per shipset decreasing, but still negative. Not necessarily collecting. Another major undertaking: 787 program? They have deferred inventory balance grew by $33M due to price step downs offset by cost improvements. Current block will end later this year, remain on plan. Not heavy phase done? No. B-21 win: early phase EMD, not collecting. 737 MAX first flight: milestone, but not heavy phase done? They are in development/production.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.